These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12476294)

  • 1. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
    Hicks K; Peng D; Gajewski JL
    Bone Marrow Transplant; 2002 Dec; 30(12):975-8. PubMed ID: 12476294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.
    Heslet L; Nielsen JD; Levi M; Sengeløv H; Johansson PI
    Crit Care; 2006; 10(6):R177. PubMed ID: 17184515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.
    Pathak V; Kuhn J; Gabriel D; Barrow J; Jennette JC; Henke DC
    Lung; 2015 Jun; 193(3):375-9. PubMed ID: 25802198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffuse alveolar hemorrhage after allogeneic bone marrow transplantation].
    Ishida T; Arita M; Fujimori N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):369-73. PubMed ID: 8778482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
    Majhail NS; Parks K; Defor TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
    Srivastava A; Gottlieb D; Bradstock KF
    Bone Marrow Transplant; 1995 Jun; 15(6):863-7. PubMed ID: 7581082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients.
    Raptis A; Mavroudis D; Suffredini A; Molldrem J; Rhee FV; Childs R; Phang S; Barrett A
    Bone Marrow Transplant; 1999 Oct; 24(8):879-83. PubMed ID: 10516700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
    Blatt J; Gold SH; Wiley JM; Monahan PE; Cooper HC; Harvey D
    Bone Marrow Transplant; 2001 Aug; 28(4):405-7. PubMed ID: 11571515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
    Shapiro AD; Gilchrist GS; Hoots WK; Cooper HA; Gastineau DA
    Thromb Haemost; 1998 Nov; 80(5):773-8. PubMed ID: 9843170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.
    Elinoff JM; Bagci U; Moriyama B; Dreiling JL; Foster B; Gormley NJ; Salit RB; Cai R; Sun J; Beri A; Reda DJ; Fakhrejahani F; Battiwalla M; Baird K; Cuellar-Rodriguez JM; Kang EM; Pavletic SZ; Fowler DH; John Barrett A; Lozier JN; Kleiner DE; Mollura DJ; Childs RW; Suffredini AF
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):969-78. PubMed ID: 24657447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.
    MacLaren R; Weber LA; Brake H; Gardner MA; Tanzi M
    Transfusion; 2005 Sep; 45(9):1434-42. PubMed ID: 16131375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII for treatment of intramuscular haemorrhages: a comparison of early versus late treatment.
    Lusher JM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S111-4. PubMed ID: 9819040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary recombinant factor VIIa for diffuse alveolar hemorrhage in children.
    Park JA; Kim BJ
    Pediatrics; 2015 Jan; 135(1):e216-20. PubMed ID: 25548333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.
    Cooper BW; Veal GJ; Radivoyevitch T; Tilby MJ; Meyerson HJ; Lazarus HM; Koc ON; Creger RJ; Pearson G; Nowell GM; Gosky D; Ingalls ST; Hoppel CL; Gerson SL
    Clin Cancer Res; 2004 Oct; 10(20):6830-9. PubMed ID: 15501959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.